Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DNA/RNA-Based Next-Generation Sequencing Improves the Early Diagnosis and Management of Neoplastic Bile Duct Strictures: A 6-Year, Prospective, Multi-Institutional, Real-Time Study.

Gastroenterology·2026
Same author

Impact of Retroactive Application of Updated Surveillance Guidelines on Endoscopy Center Capacity at a Large VA Health Care System.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2026
Same author

PancreaSeq Genomic Classifier (PancreaSeq GC) Improves Pancreatic Cyst Classification and Detection of Advanced Neoplasia: A Multi-institutional Validation Study.

Annals of surgical oncology·2025
Same author

Carbon dots as probes in FLIM:a review of applications and advances in cellular imaging.

RSC advances·2025
Same author

Complete Cytoreduction of Colorectal Liver Metastases: Evolving Systemic Therapy and Liver Transplantation.

Journal of surgical oncology·2025
Same author

Recurrent BEND2 Fusion Genes Identified by Whole Transcriptome Sequencing of Nonfunctional Pancreatic Neuroendocrine Tumors Correlate With Poor Patient Prognosis.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2025

Related Experiment Video

Updated: Jul 14, 2026

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models
09:18

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models

Published on: February 3, 2026

Multimodality therapy for pancreatic cancer.

Jan Franko1, Julia B Greer, Coleen M Moran

  • 1Division of Surgical Oncology, University of Pittsburgh Medical Center, 497 Scaife Hall, 3550 Terrace Street, Pittsburgh, PA 15261, USA.

Gastroenterology Clinics of North America
|May 30, 2007
PubMed
Summary

Neoadjuvant chemoradiotherapy is safe for pancreatic cancer patients, but its benefits over adjuvant therapy are unclear. Further research requires a large, collaborative trial to confirm efficacy and advance pancreatic cancer treatment.

Related Experiment Videos

Last Updated: Jul 14, 2026

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models
09:18

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models

Published on: February 3, 2026

Area of Science:

  • Oncology
  • Surgical Oncology
  • Gastroenterology

Background:

  • Pancreatic cancer treatment often involves surgery, chemotherapy, and radiation.
  • Neoadjuvant chemoradiotherapy (nCRT) is an option, but its efficacy compared to adjuvant therapy is not well-established.
  • Complete pathologic responses to nCRT are infrequent, raising questions about its overall benefit.

Purpose of the Study:

  • To evaluate the safety and efficacy of neoadjuvant chemoradiotherapy (nCRT) in pancreatic cancer.
  • To compare nCRT with standard adjuvant therapy and surgery alone.
  • To establish the need for a prospective, multi-institutional trial for definitive evaluation.

Main Methods:

  • The study discusses the design of a prospective clinical trial.
  • The trial would compare outcomes of pancreatic cancer patients receiving nCRT, adjuvant therapy, or surgery alone.
  • Emphasis is placed on uniform patient populations and careful coordination for statistical power.

Main Results:

  • Neoadjuvant chemoradiotherapy can be administered safely in pancreatic cancer patients.
  • Complete pathologic responses are rare, indicating limited tumor eradication.
  • The comparative benefits of nCRT versus adjuvant therapy remain uncertain.

Conclusions:

  • A definitive prospective trial is necessary to ascertain the efficacy of nCRT for pancreatic cancer.
  • Such a trial requires multi-institutional collaboration and rigorous design for conclusive results.
  • Advancing pancreatic cancer research depends on translating laboratory innovations into clinical practice.